Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design.
about
Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial.Current recommendations and emerging options for the treatment of allergic rhinitis.Update on rupatadine in the management of allergic disorders.Rupatadine: global safety evaluation in allergic rhinitis and urticaria.Sedative Effects of Levocetirizine: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.
P2860
Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Evaluation of nasal symptoms i ...... in a cross-over study design.
@ast
Evaluation of nasal symptoms i ...... in a cross-over study design.
@en
type
label
Evaluation of nasal symptoms i ...... in a cross-over study design.
@ast
Evaluation of nasal symptoms i ...... in a cross-over study design.
@en
prefLabel
Evaluation of nasal symptoms i ...... in a cross-over study design.
@ast
Evaluation of nasal symptoms i ...... in a cross-over study design.
@en
P2093
P2860
P356
P1476
Evaluation of nasal symptoms i ...... o in a cross-over study design
@en
P2093
Alejandro Doménech
Antonio Valero
Cesar Picado
Ignacio Izquierdo
Jaume Sánchez-López
Joan Bartra
Joaquim Mullol
P2860
P2888
P356
10.1186/1710-1492-9-43
P50
P577
2013-11-01T00:00:00Z
P5875
P6179
1041753245